Embolization of Polycystic Kidneys as an Alternative to Nephrectomy Before Renal Transplantation: A Pilot Study

F. Cornelis, L. Couzi, P. Merville and N. Grenier contributed equally to this work.
https://doi.org/10.1111/j.1600-6143.2010.03251.xGet rights and content
Under a Creative Commons license
open archive

In autosomal polycystic kidney disease, nephrectomy is required before transplantation if kidney volume is excessive. We evaluated the effectiveness of transcatheter arterial embolization (TAE) to obtain sufficient volume reduction for graft implantation. From March 2007 to December 2009, 25 patients with kidneys descending below the iliac crest had unilateral renal TAE associated with a postembolization syndrome protocol. Volume reduction was evaluated by CT before, 3, and 6 months after embolization. The strategy was considered a success if the temporary contraindication for renal transplantation could be withdrawn within 6 months after TAE. TAE was well tolerated and the objective was reached in 21 patients. The temporary contraindication for transplantation was withdrawn within 3 months after TAE in 9 patients and within 6 months in 12 additional patients. The mean reduction in volume was 42% at 3 months (p = 0.01) and 54% at 6 months (p = 0.001). One patient required a cyst sclerosis to reach the objective. The absence of sufficient volume reduction was due to an excessive basal renal volume, a missed accessory artery and/or renal artery revascularization. Embolization of enlarged polycystic kidneys appears to be an advantageous alternative to nephrectomy before renal transplantation.

Key words:

Autosomal dominant polycystic kidney disease
renal embolization
renal transplantation

Abbreviations:

ADPKD
autosomal dominant polycystic kidney disease
TAE
transcatheter arterial embolization
VEGF
vascular endothelial growth factor
MPR
multiplanar reconstruction
PVA
polyvinyl alcohol

Cited by (0)